Ongoing phase 1/2 study of INCB050465 for relapsed/refractory (R/R) B-cell malignancies (CITADEL-101)

Category Primary study
JournalJournal of Clinical Oncology
Year 2017
This article has no abstract
Epistemonikos ID: cdb4599c73bd7fb6e463d4bdd327ff4e9a92d823
First added on: Feb 08, 2025